3Sweeney MH, MocareUi P. Human health effects after exposureto 2, 3, 7, 8 - TCDD [J]. Food Addit Contam, 2000, 17(4): 303-316.
4BaccareUi A, Pesatori AC, Consonni D, et al. Health status andplasma dioxin levels in chloracne cases 20 years after the Seveso, Italy accident [J]. Br J Dermatol, 2005, 152 (3): 459-465.
5Coenraads PJ, Brouwer A, Olie K, et al. Chloraene. Some recentissues [J]. Dermatol Clin, 1994, 12 (3): 569-576.
6Davies MW, Dore AJ, Perissinotto KL. Topical vitamin A, or itsderivatives, for treating and preventing napkin dermatitis in infants[J]. Cochrane Database Syst Rev, 2005, (4): CD004300.
7David Alberts, James Ranger-Moore, Janine Einspahr, et al.Safety and efficacy of dose-intensive oral vitamin A in subjects withsun-damaged skin [J]. Clin Cancer Res, 2004, 10: 1875 -1880.
9Vos JG, Beems RB. Dermal toxicity studies of technical polychlorinated biphenyls and fractions thereof in rabbits [J]. ToxicolAppl Pharmacol, 1971, 19 (4): 617-633.
10Coenraads PJ, Brouwer A, Tang NJ. Chloracne: insufficient evidence for inter ference with retinal metabolism in workers exposedto dioxins and dibenzofuranes [J]. J Invest Dermatol, 1991,78 : 424 - 424.
